Global Market Study on Injectable Nanomedicines

Dec 2018| PMR1093A| Persistence Market Research

Report Highlights

A recent market study published by the company – “Injectable nanomedicines: Global Industry Analysis 2013 – 2017 and Forecast 2018 – 2026”, consists a comprehensive assessment of the most important market dynamics. By conducting a thorough research on the historic as well as current growth parameters of the injectable nanomedicines market, the growth prospects of the market are obtained with maximum precision. The report features unique and salient factors that may have a huge impact on the development of the injectable nanomedicines market during the forecast period. It can help the players to modify their manufacturing and marketing strategies to envisage maximum growth in the injectable nanomedicines in the upcoming years. The report provides detailed information about the current and future growth prospects of the injectable nanomedicines market in the most comprehensive way for better understanding of the readers.

Chapter 1 – Executive Summary

The report commences with the executive summary of the injectable nanomedicines market, which includes the summary of key findings and key statistics of the market. It also includes the market value (US$ million) estimates of the leading segments of the injectable nanomedicines market.

Chapter 2 – Market Overview

Readers can find detailed taxonomy and the definition of the injectable nanomedicines in this chapter, which will help them to understand the basic information about the injectable nanomedicines market dynamics, regulatory scenarios, pipeline assessment, disease epidemiology, reimbursement scenarios, and list of the key participants included in the report.

Chapter 3 – Global Injectable nanomedicines Market Global Industry Analysis 2013 – 2017 and Forecast 2018 – 2026, By Drug Type

Based on the drug type, the injectable nanomedicines market is segmented into liposomes, micelles, nanocrystals, polymeric nanoparticles and metallic nanoparticles, mesoporous silica nanoparticles and others.  In this chapter, readers can find information about key trends and developments in the injectable nanomedicines market and market attractive analysis based on the type of drug products.  

Chapter 4 – Global Injectable nanomedicines Global Industry Analysis 2013 – 2017 and Forecast 2018 – 2026, By Application Type

Based on the disease indication, the injectable nanomedicines market is segmented into cancer, central nervous system disease, cardiovascular disease, infection control, inflammatory disease and others. In this chapter, readers can find information about key trends and developments in the injectable nanomedicines market and market attractive analysis based on application type.

Chapter 5 – Global Injectable nanomedicines Global Industry Analysis 2013 – 2017 and Forecast 2018 – 2026, By End user

Based on the end user, the injectable nanomedicines market is segmented into hospital, ambulatory surgical centers, clinics, specialized drugs R&D institutes, managed care organizations. In this chapter, readers can find information about key trends and developments in the injectable nanomedicines market and market attractive analysis based on end user.

Chapter 6 – Global Injectable nanomedicines Global Industry Analysis 2013 – 2017 and Forecast 2018 – 2026, By Region

This chapter explains how the injectable nanomedicines market will grow across various geographic regions, such as North America, Latin America, Europe, Asia-Pacific and Middle East & Africa (MEA).

Chapter 7 – North America Injectable nanomedicines Global Industry Analysis 2013 – 2017 and Forecast 2018 – 2026

This chapter includes detailed analysis of the growth of the North America injectable nanomedicines market along with the country-wise assessment including the U.S. and Canada. Readers can also find regional trends, regulations, and market growth based on drug type, application, end user and countries of injectable nanomedicines market in North America.

Chapter 8 – Latin America Injectable nanomedicines Global Industry Analysis 2013 – 2017 and Forecast 2018 – 2026

Readers can find detailed information about factors such as, regulatory scenarios, and regional trends that are impacting the growth of the Latin America injectable nanomedicines market. This chapter also includes the growth prospects of the injectable nanomedicines market in leading LATAM countries such as Brazil, Mexico and Rest of the Latin America.

Chapter 9 – Europe Injectable nanomedicines Global Industry Analysis 2013 – 2017 and Forecast 2018 – 2026

Important growth prospects of the injectable nanomedicines market based on its product types, form, and applications in several European countries, such as EU4, the U.K., BENELUX, Nordic, and Rest of Europe.

Chapter 10 – APAC Injectable nanomedicines Global Industry Analysis 2013 – 2017 and Forecast 2018 – 2026

Great China, India, ASEAN, Australia and New Zealand are the leading countries in the APAC region that are the prime subject of assessment to obtain growth prospects of the APAC injectable nanomedicines market in this chapter. Readers can find thorough information about the growth parameters of the APAC injectable nanomedicines market during the period 2018-2026.

Chapter 11 – MEA Injectable nanomedicines Global Industry Analysis 2013 – 2017 and Forecast 2018 – 2026

This chapter provides information on how the injectable nanomedicines market will grow in the major countries in MEA region, such as GCC Countries, Turkey, Iran, Israel, and South Africa, during the period 2018-2026.

Chapter 12 – Competition Landscape, Company Share and Company Profiles

In this chapter, readers can find a comprehensive list of all the leading stakeholders in the injectable nanomedicines market along with detailed information about each company, including company overview, revenue shares, strategic overview, and recent company developments. The players featured in the report include Merck & Co, Inc., Amgen Inc., Pfizer Inc., Lupin, Janssen Biotech Inc., Hoffmann-La Roche Ltd., Teva Pharmaceutical Industries Ltd., Pacira Pharmaceuticals Inc., Celgene Corporation and  Bausch & Lomb Incorporated.

Chapter 13 – Assumptions and Acronyms

This chapter includes a list of acronyms and assumptions that provide a base to the information and statistics included in the report.

Chapter 14 – Research Methodology

This chapter helps readers to understand the research methodology followed to obtain various conclusions, important qualitative information, and quantitative information about the injectable nanomedicines market.

  • Table 1 : Parameters For Quality And Safety Evaluation Of Nanotechnology-based Medicinal Products For Biomedical Use
  • Table 2 : Commercial Available Injectable Nanomedicines (1/3)
  • Table 3 : Commercial Available Injectable Nanomedicines (2/3)
  • Table 4 : Commercial Available Injectable Nanomedicines (3/3)
  • Table 5 : North America Injectable Nanomedicines Market Size (US$ Mn) Analysis 2013�2017 and Forecast 2018�2026, By Country
  • Table 6 : North America Injectable Nanomedicines Market Size (US$ Mn) Analysis 2013�2017 and Forecast 2018�2026, By Drug Type
  • Table 7 : North America Injectable Nanomedicines Market Size (US$ Mn) Analysis 2013�2017 and Forecast 2018�2026, By Application
  • Table 8 : North America Injectable Nanomedicines Market Size (US$ Mn) Analysis 2013�2017 and Forecast 2018�2026, By End User
  • Table 9 : Latin America Injectable Nanomedicines Market Size (US$ Mn) Analysis 2013�2017 and Forecast 2018�2026, By Country
  • Table 10 : Latin America Injectable Nanomedicines Market Size (US$ Mn) Analysis 2013�2017 and Forecast 2018�2026, By Drug Type
  • Table 11 : Latin America Injectable Nanomedicines Market Size (US$ Mn) Analysis 2013�2017 and Forecast 2018�2026, By Application
  • Table 12 : Latin America Injectable Nanomedicines Market Size (US$ Mn) Analysis 2013�2017 and Forecast 2018�2026, By End User
  • Table 13 : Europe Injectable Nanomedicines Market Size (US$ Mn) Analysis 2013�2017 and Forecast 2018�2026, By Country
  • Table 14 : Europe Injectable Nanomedicines Market Size (US$ Mn) Analysis 2013�2017 and Forecast 2018�2026, By Drug Type
  • Table 15 : Europe Injectable Nanomedicines Market Size (US$ Mn) Analysis 2013�2017 and Forecast 2018�2026, By Application
  • Table 16 : Europe Injectable Nanomedicines Market Size (US$ Mn) Analysis 2013�2017 and Forecast 2018�2026, By End User
  • Table 17 : Asia Pacific Injectable Nanomedicines Market Size (US$ Mn) Analysis 2013�2017 and Forecast 2018�2026, By Country
  • Table 18 : Asia Pacific Injectable Nanomedicines Market Size (US$ Mn) Analysis 2013�2017 and Forecast 2018�2026, By Drug Type
  • Table 19 : Asia Pacific Injectable Nanomedicines Market Size (US$ Mn) Analysis 2013�2017 and Forecast 2018�2026, By Application
  • Table 20 : Asia Pacific Injectable Nanomedicines Market Size (US$ Mn) Analysis 2013�2017 and Forecast 2018�2026, By End User
  • Table 21 : Middle East & Africa Injectable Nanomedicines Market Size (US$ Mn) Analysis 2013�2017 and Forecast 2018�2026, By Country
  • Table 22 : Middle East & Africa Injectable Nanomedicines Market Size (US$ Mn) Analysis 2013�2017 and Forecast 2018�2026, By Drug Type
  • Table 23 : Middle East & Africa Injectable Nanomedicines Market Size (US$ Mn) Analysis 2013�2017 and Forecast 2018�2026, By Application
  • Table 24 : Middle East & Africa Injectable Nanomedicines Market Size (US$ Mn) Analysis 2013�2017 and Forecast 2018�2026, By End User
  • Table 25 : Global Injectable Nanomedicines Market Size (US$ Mn) Analysis 2013�2017 and Forecast 2018�2026, By Region
  • Table 26 : Global Injectable Nanomedicines Market Size (US$ Mn) Analysis 2013�2017 and Forecast 2018�2026, By Drug Type
  • Table 27 : Global Injectable Nanomedicines Market Size (US$ Mn) Analysis 2013�2017 and Forecast 2018�2026, By Application
  • Table 28 : Global Injectable Nanomedicines Market Size (US$ Mn) Analysis 2013�2017 and Forecast 2018�2026, By End User
  • Figure 1 : Injectable Nanomedicines Market Value Share By Region (2018)
  • Figure 2 : Global Injectable Nanomedicines Market Value Share, by Country (2017)
  • Figure 3 : Global Injectable Nanomedicines Market Value Share, by Drug Type (2017)
  • Figure 4 : Global Injectable Nanomedicines Market Value Share, by Application (2017)
  • Figure 5 : Global Injectable Nanomedicines Market Value Share, by End User (2017)
  • Figure 6 : North America Injectable Nanomedicines Market, Snapshot
  • Figure 7 : North America Injectable Nanomedicines Market Value Share, by Country (2017)
  • Figure 8 : North America Injectable Nanomedicines Market Value Share, by Drug Type (2017)
  • Figure 9 : North America Injectable Nanomedicines Market Value Share, by Application (2017)
  • Figure 10 : North America Injectable Nanomedicines Market Value Share, by End User (2017)
  • Figure 11 : North America Injectable Nanomedicines Market Size (US$ Mn) Analysis, 2013�2017
  • Figure 12 : North America Injectable Nanomedicines Market Size (US$ Mn) Forecast & Y-o-Y Growth (%), 2018�2026
  • Figure 13 : North America Injectable Nanomedicines Market Attractiveness Analysis, By Country
  • Figure 14 : North America Injectable Nanomedicines Market Attractiveness Analysis, By Drug Type
  • Figure 15 : North America Injectable Nanomedicines Market Attractiveness Analysis, By Application
  • Figure 16 : North America Injectable Nanomedicines Market Attractiveness Analysis, By End User
  • Figure 17 : Latin America Injectable Nanomedicines Market, Snapshot
  • Figure 18 : Latin America Injectable Nanomedicines Market Value Share, by Country (2017)
  • Figure 19 : Latin America Injectable Nanomedicines Market Value Share, by Drug Type (2017)
  • Figure 20 : Latin America Injectable Nanomedicines Market Value Share, by Application (2017)
  • Figure 21 : Latin America Injectable Nanomedicines Market Value Share, by End User (2017)
  • Figure 22 : Latin America Injectable Nanomedicines Market Size (US$ Mn) Analysis, 2013�2017
  • Figure 23 : Latin America Injectable Nanomedicines Market Size (US$ Mn) Forecast & Y-o-Y Growth (%), 2018�2026
  • Figure 24 : Latin America Injectable Nanomedicines Market Attractiveness Analysis, By Country
  • Figure 25 : Latin America Injectable Nanomedicines Market Attractiveness Analysis, By Drug Type
  • Figure 26 : Latin America Injectable Nanomedicines Market Attractiveness Analysis, By Application
  • Figure 27 : Latin America Injectable Nanomedicines Market Attractiveness Analysis, By End User
  • Figure 28 : Europe Injectable Nanomedicines Market, Snapshot
  • Figure 29 : Europe Injectable Nanomedicines Market Value Share, by Country (2017)
  • Figure 30 : Europe Injectable Nanomedicines Market Value Share, by Drug Type (2017)
  • Figure 31 : Europe Injectable Nanomedicines Market Value Share, by Application (2017)
  • Figure 32 : Europe Injectable Nanomedicines Market Value Share, by End User (2017)
  • Figure 33 : Europe Injectable Nanomedicines Market Size (US$ Mn) Analysis, 2013�2017
  • Figure 34 : Europe Injectable Nanomedicines Market Size (US$ Mn) Forecast & Y-o-Y Growth (%), 2018�2026
  • Figure 35 : Europe Injectable Nanomedicines Market Attractiveness Analysis, By Country
  • Figure 36 : Europe Injectable Nanomedicines Market Attractiveness Analysis, By Drug Type
  • Figure 37 : Europe Injectable Nanomedicines Market Attractiveness Analysis, By Application
  • Figure 38 : Europe Injectable Nanomedicines Market Attractiveness Analysis, By End User
  • Figure 39 : Asia Pacific Injectable Nanomedicines Market, Snapshot
  • Figure 40 : Asia Pacific Injectable Nanomedicines Market Value Share, by Country (2017)
  • Figure 41 : Asia Pacific Injectable Nanomedicines Market Value Share, by Drug Type (2017)
  • Figure 42 : Asia Pacific Injectable Nanomedicines Market Value Share, by Application (2017)
  • Figure 43 : Asia Pacific Injectable Nanomedicines Market Value Share, by End User (2017)
  • Figure 44 : Asia Pacific Injectable Nanomedicines Market Size (US$ Mn) Analysis, 2013�2017
  • Figure 45 : Asia Pacific Injectable Nanomedicines Market Size (US$ Mn) Forecast & Y-o-Y Growth (%), 2018�2026
  • Figure 46 : Asia Pacific Injectable Nanomedicines Market Attractiveness Analysis, By Country
  • Figure 47 : Asia Pacific Injectable Nanomedicines Market Attractiveness Analysis, By Drug Type
  • Figure 48 : Asia Pacific Injectable Nanomedicines Market Attractiveness Analysis, By Application
  • Figure 49 : Asia Pacific Injectable Nanomedicines Market Attractiveness Analysis, By End User
  • Figure 50 : Middle East & Africa Injectable Nanomedicines Market, Snapshot
  • Figure 51 : Middle East & Africa Injectable Nanomedicines Market Value Share, by Country (2017)
  • Figure 52 : Middle East & Africa Injectable Nanomedicines Market Value Share, by Drug Type (2017)
  • Figure 53 : Middle East & Africa Injectable Nanomedicines Market Value Share, by Application (2017)
  • Figure 54 : Middle East & Africa Injectable Nanomedicines Market Value Share, by End User (2017)
  • Figure 55 : Middle East & Africa Injectable Nanomedicines Market Size (US$ Mn) Analysis, 2013�2017
  • Figure 56 : Middle East & Africa Injectable Nanomedicines Market Size (US$ Mn) Forecast & Y-o-Y Growth (%), 2018�2026
  • Figure 57 : Middle East & Africa Injectable Nanomedicines Market Attractiveness Analysis, By Country
  • Figure 58 : Middle East & Africa Injectable Nanomedicines Market Attractiveness Analysis, By Drug Type
  • Figure 59 : Middle East & Africa Injectable Nanomedicines Market Attractiveness Analysis, By Application
  • Figure 60 : Middle East & Africa Injectable Nanomedicines Market Attractiveness Analysis, By End User
  • Figure 61 : Global Injectable Nanomedicines Market Attractiveness Analysis, By Region
  • Figure 62 : Global Injectable Nanomedicines Market Value Share Analysis, By Region, 2017 & 2026
  • Figure 63 : Global Injectable Nanomedicines Market Attractiveness Analysis, By Drug Type
  • Figure 64 : Global Injectable Nanomedicines Market Value Share Analysis, By Drug Type, 2017 & 2026
  • Figure 65 : Global Injectable Nanomedicines Market Attractiveness Analysis, By Application
  • Figure 66 : Global Injectable Nanomedicines Market Value Share Analysis, By Application, 2017 & 2026
  • Figure 67 : Global Injectable Nanomedicines Market Attractiveness Analysis, By End User
  • Figure 68 : Global Injectable Nanomedicines Market Value Share Analysis, By End User, 2017 & 2026
  • Figure 69 : Global Injectable Nanomedicines Market Size (US$ Mn) Analysis, 2013�2017
  • Figure 70 : Global Injectable Nanomedicines Market Size (US$ Mn) Forecast & Y-o-Y Growth (%), 2018�2026
  • Figure 71 : Global Injectable Nanomedicines Market Absolute $ Opportunity, 2013�2026

Persistence Market Research (PMR) is a third-platform research firm. Our research model is a unique collaboration of data analytics and market research methodology to help businesses achieve optimal performance.

To support companies in overcoming complex business challenges, we follow a multi-disciplinary approach. At PMR, we unite various data streams from multi-dimensional sources. By deploying real-time data collection, big data, and customer experience analytics, we deliver business intelligence for organization of all sizes.

Why BCC Research?

Every purchase provides access to:

  • Thousands of recently published reports from select publishers
  • Discounts of up to 50% on over 20,000 additional reports from all publishers
  • Our analysts and research concierge for all inquiries
CUSTOM RESEARCH

Need a custom data table, graph or complete report? Tell us more.

Contact Us
Share This Report